Scope
This guide addresses the control gaps that emerge when you're implementing System and Organization Controls (SOC) 2 or ISO/IEC 27001 in organizations deploying AI-driven diagnostics, remote patient monitoring, predictive analytics, or other emerging healthcare technologies. It's written for compliance managers who need to extend existing controls to cover risks these frameworks weren't originally designed to address.
You won't find prescriptive healthcare regulations here. This focuses on how to adapt your information security management system (ISMS) or trust services criteria to handle the ethical and privacy dimensions that standard control sets overlook.
Key Concepts and Definitions
Emerging Healthcare Technology: For compliance purposes, any system that processes protected health information using machine learning, algorithmic decision-making, continuous biometric monitoring, or predictive modeling where the processing logic evolves independently of manual configuration changes.
Ethical Control Objective: A control designed to prevent foreseeable harm from system behavior that's technically compliant but ethically problematic. Example: An access control that's properly configured but grants algorithmic decision authority without human oversight in life-critical scenarios.
Privacy by Design Requirement: ISO/IEC 27001:2022 Annex A Control 5.34 addresses privacy and protection of personally identifiable information (PII), but it doesn't mandate privacy-preserving architecture. You'll need to interpret this control more strictly for healthcare contexts.
Requirements Breakdown
SOC 2 Trust Services Criteria Gaps
CC6.1 (Logical and Physical Access Controls) requires you to restrict access to information assets. When your "information asset" is a trained machine learning model that makes diagnostic recommendations, standard role-based access control doesn't address who can modify training data or retrain the model.
You're compliant if your engineers have proper authentication. You're not addressing the actual risk if those engineers can introduce bias into clinical decision support without clinical oversight.
CC7.2 (System Monitoring) covers detection of anomalies and incidents. Your SIEM alerts on failed login attempts. It doesn't alert when an algorithm's false negative rate for a specific demographic group drifts outside acceptable parameters.
CC9.1 (Risk Mitigation) requires identification and mitigation of risks. Standard risk registers capture "unauthorized access to patient data." They rarely capture "algorithmic recommendation causes differential treatment outcomes across patient populations."
ISO/IEC 27001:2022 Annex A Control Gaps
Control 5.7 (Threat Intelligence) requires you to collect and analyze threat information. When your threat is model degradation or training data poisoning rather than network intrusion, your threat intelligence feeds won't help.
Control 8.16 (Monitoring Activities) mandates monitoring for anomalous behavior. Define what's "anomalous" when your system's designed to learn and change behavior autonomously.
Control 5.34 (Privacy and Protection of PII) is your strongest hook for healthcare-specific requirements, but the control text doesn't specify fairness testing, algorithmic transparency, or differential privacy techniques.
Implementation Guidance
Extend Your Risk Assessment Process
Add a scenario-based risk assessment specifically for algorithmic systems. For each technology deployment, document:
- Decision Authority: What clinical or operational decisions does the system make autonomously?
- Reversibility: Can a human override the system's output before it affects patient care?
- Explainability: Can the system provide clinically meaningful justification for its outputs?
- Bias Surface: What demographic variables exist in training data, and have you tested for differential outcomes?
Map these to your existing risk treatment plan. If you're using ISO/IEC 27001, this extends your Clause 6.1.2 risk assessment. If you're using SOC 2, it strengthens your CC3.2 risk identification process.
Create Ethical Review Controls
Establish a control that requires clinical or ethical review before deploying systems that make autonomous decisions affecting patient care. Document this as a compensating control that addresses risks outside your standard control set's scope.
Your control description might specify:
- Review panel composition (must include clinical expertise, not just IT security)
- Review triggers (any system update that changes decision logic or training data)
- Documentation requirements (fairness testing results, bias analysis, explainability assessment)
- Approval authority (cannot be the same team that developed the system)
Modify Your Change Management Process
If you're following Control 8.32 (Change Management) in ISO/IEC 27001, add a gate specifically for algorithmic systems. Standard change management asks "will this break production?" You need to also ask "will this change model behavior in ways that create differential outcomes?"
For SOC 2 organizations, this extends CC8.1. Your change approval process should require:
- Comparison of model performance metrics before and after changes, segmented by relevant demographic variables
- Review of any changes to training data sources or feature engineering
- Testing results showing the change doesn't degrade fairness metrics
Strengthen Your Privacy Controls
Control 5.34 in ISO/IEC 27001:2022 gives you the authority to implement privacy-preserving techniques. For healthcare technologies, specify:
- Differential Privacy: When you're using patient data for model training, document your privacy budget and noise injection approach
- Federated Learning: If you're training models across multiple datasets without centralizing patient records, document your architectural controls
- Data Minimization: Require justification for each data element used in model training, not just data elements stored in production databases
Common Pitfalls
Treating Algorithmic Systems Like Standard Applications: Your penetration testing and vulnerability scanning controls don't assess fairness, bias, or explainability. Don't assume you've covered these risks because you've met CC7.1 or Control 8.8.
Relying on Vendor Attestations: If you're using a third-party healthcare AI platform, their SOC 2 Type II report proves they have access controls and change management. It doesn't prove their algorithm is fair or their training data is representative. You need Complementary Subservice Organization Controls, not just Complementary Subservice Organization Controls.
Confusing Compliance with Safety: You can be fully compliant with every control in Annex A and still deploy a system that produces biased clinical recommendations. Compliance frameworks establish security baselines; they don't guarantee ethical outcomes.
Ignoring Model Drift: You've implemented Control 8.16 monitoring for infrastructure. If you're not monitoring model performance metrics over time, you're missing the most significant risk in autonomous systems.
Skipping Clinical Validation: Your security team validated that the system meets technical requirements. That's not the same as clinical validation showing the system's outputs are medically sound across patient populations.
Quick Reference Table
| Risk Category | Relevant SOC 2 Criteria | Relevant ISO/IEC 27001 Controls | Gap to Address |
|---|---|---|---|
| Algorithmic bias | CC9.1 (Risk Mitigation) | 5.7 (Threat Intelligence), 8.16 (Monitoring) | Add fairness testing and demographic segmentation to monitoring |
| Training data integrity | CC6.1 (Access Controls) | 8.3 (Information Access Restriction) | Extend access controls to cover training datasets and model retraining |
| Autonomous decision-making | CC3.2 (Risk Identification) | 6.1.2 (Risk Assessment) | Add ethical review gate for systems with clinical decision authority |
| Model explainability | CC7.2 (System Monitoring) | 8.16 (Monitoring Activities) | Document explainability requirements and testing approach |
| Privacy-preserving architecture | PI1.5 (Privacy by Design) | 5.34 (Privacy and Protection of PII) | Specify differential privacy, federated learning, or other techniques |
| Vendor AI/ML systems | CC9.2 (Vendor Management) | 5.19 (Supplier Relationships) | Require fairness and bias testing evidence beyond standard SOC 2 reports |
Your existing frameworks give you the structure to build these controls. They don't tell you which controls to build. That's your job.
